Sabby Management’s AbbVie ABBV Stock Holding History

Sabby Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27,559	Closed	-$3.03M	–	156
2017 Q4	$2.67M	Buy	+27,559	New	+$2.6M	0.24%	47
2016 Q1	–	Sell	-46,166	Closed	-$2.57M	–	297
2015 Q4	$2.73M	Buy	46,166 +22,650	+96%	+$1.3M	0.15%	101
2015 Q3	$1.28M	Buy	+23,516	New	+$1.53M	0.05%	208
2013 Q3	–	Sell	-355,626	Closed	-$14.7M	–	195
2013 Q2	$14.7M	Buy	+355,626	New	+$15.6M	0.98%	25

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sabby Management's ABBV Position: Q1 2018 in Review

Sabby Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 27,559 shares — an estimated $3.03M sold.

Sabby Management first reported a position in ABBV in Q2 2013 and held it in 4 quarters. The position peaked at $14.7M in Q2 2013. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Sabby Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Sabby Management sold 27,559 AbbVie shares in Q1 2018, an estimated $3.03M.
Sabby Management first reported a position in AbbVie in Q2 2013 and held it in 4 quarters.
Sabby Management's AbbVie position peaked at $14.7M in Q2 2013.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.